Delivery Order SPE2DB24D8001-SPE2DB24FKZAF

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,480.37, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. valued at $999,999,999.00. This delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate...
This federal contract award, valued at $2,477.84, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. The contract is structured as a firm fixed-price delivery order with a completion date of September 10, 2024. Dakota Drug, Inc. also holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,250.46 firm fixed-price delivery order is for the provision of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract is an Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,627.89, is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 and a performance period through December 31, 2025. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This award...
This federal contract award, valued at $1,252.44, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used to treat diabetes. The contract is a firm fixed-price delivery order without a set-aside designation. It has an ultimate completion date of August 1, 2024. Dakota Drug, Inc. holds...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division was issued to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,589.50, is a firm fixed-price delivery order to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the DLA. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001, valued at $999,999,999.00. This...
This federal contract award, identified as SPE2DX15D8002|SPE2DX23F2UP6, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,318.96, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Dakota Drug, Inc. is a key supplier to the DLA, holding a...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,418.80 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of November 8, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces...
This federal contract award, valued at $1,385.83, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001, is a delivery order awarded under the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) that allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in the System for Award Management (SAM.gov). The $13,783.74 firm fixed-price delivery order is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a performance period through November 19, 2024 and was awarded on November 18, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB24FKZAF
    Delivery Order

This federal contract award, valued at $1,361.18, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a delivery order under DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. The specific product being provided is the TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. This contract does not have a set-aside designation. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This IDC positions Dakota Drug, Inc. as a key supplier for DLA's military medical supply programs.

Generated 12/9/24, 2:08 PM